CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-06 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +2,406 | $10.76 | $26K | 25,364 |
| 2024-12-06 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −8,969 | $21.27 | $191K | 22,958 |
| 2024-12-06 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −2,406 | 24,528 | ||
| 2024-12-05 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,123 | $10.76 | $12K | 24,081 |
| 2024-12-05 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,123 | $21.25 | $24K | 22,958 |
| 2024-12-05 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −1,123 | 26,934 | ||
| 2024-12-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +5,024 | $10.76 | $54K | 27,982 |
| 2024-12-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −5,024 | $21.25 | $107K | 22,958 |
| 2024-12-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −5,024 | 28,057 | ||
| 2024-12-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +8,969 | $10.76 | $97K | 31,927 |
| 2024-12-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −8,969 | $21.45 | $192K | 22,958 |
| 2024-12-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −8,969 | 33,081 | ||
| 2024-11-29 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +9 | $11.10 | $100 | 26,537 |
| 2024-11-29 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9 | $22.45 | $202 | 26,528 |
| 2024-11-29 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −9 | 22,814 | ||
| 2024-11-27 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +8,637 | $11.10 | $96K | 35,165 |
| 2024-11-27 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −8,637 | $22.45 | $194K | 26,528 |
| 2024-11-27 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −8,637 | 22,823 | ||
| 2024-11-18 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,000 | $1.59 | $16K | 119,975 |
| 2024-11-18 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −17,000 | $21.04 | $358K | 102,975 |
Page 44 of 74 · 1,467 trades